According to Roche's latest financial reports the company's current EPS (TTM) is $30.02. In 2022 the company made an earnings per share (EPS) of $30.02 a decrease over its 2021 EPS that were of $32.03.
Year | EPS | Change |
---|---|---|
2022 | $30.02 | -6.29% |
2021 | $32.03 | -5.53% |
2020 | $33.91 | 16.56% |
2019 | $29.09 | 30.3% |
2018 | $22.32 | 20.22% |
2017 | $18.57 | -5.81% |
2016 | $19.71 | 4.62% |
2015 | $18.84 | -5.13% |
2014 | $19.86 | -25.05% |
2013 | $26.50 | 21.73% |
2012 | $21.77 | 3.82% |
2011 | $20.97 | 8.16% |
2010 | $19.39 | 23.72% |
2009 | $15.67 | -12.31% |
2008 | $17.87 | -0.34% |
2007 | $17.93 | 32.13% |
2006 | $13.57 | 42.56% |
2005 | $9.52 | -22.7% |
2004 | $12.31 | 132.85% |
2003 | $5.29 | -154.73% |
2002 | -$9.66 | -209.09% |
2001 | $8.86 | -57.25% |
2000 | $20.72 | 54.06% |
1999 | $13.45 | 31.24% |
1998 | $10.25 |